by | Jul 31, 2025 | Lupus Foundation of America
This afternoon, the Senate Appropriations Committee approved legislation to fund government health programs for FY 2026, including lupus-specific programs championed by the Lupus Foundation of America and lupus advocates across the country. The bill includes:$10...
by | Jul 30, 2025 | Lupus Foundation of America
The Lupus Foundation of America, the national force devoted to solving the cruel mystery of lupus, announced the appointment of Brad H. Rovin, MD, FACP, FASN, as Chair of its Medical-Scientific Advisory Council (MSAC). Dr. Rovin succeeds Karen Costenbader, MD, MPH,...
by | Jul 25, 2025 | Lupus Foundation of America, News & Events
A new study found an association between hydroxychloroquine (HCQ) use and early and long-term benefits on kidney function in people with lupus nephritis, (LN, lupus-related kidney disease). HCQ (known commercially as Plaquenil®) is safe and widely used to support more...
by | Jul 24, 2025 | Lupus Foundation of America
The Lupus Foundation of America (LFA) and Lupus Canada are pleased to announce Mohamed Osman, MD, PhD, Associate Professor of Rheumatology at University of Alberta, as the recipient of the 2025 Lupus Canada Catalyst Award. His study “Defining the molecular drivers of...
by | Jul 24, 2025 | Lupus Foundation of America, News & Events
A recent dual-cohort  study has found that Lupus Low Disease Activity State (LLDAS) is an attainable and effective treatment target for people with lupus nephritis (LN, lupus-related kidney disease). LN affects 50-60% of those with systemic lupus erythematosus (SLE)...
by | Jul 22, 2025 | Lupus Foundation of America, News & Events
A new study found a high prevalence of chronic kidney disease (CKD) among people with systemic lupus erythematosus (SLE), including in people without a diagnosis of lupus nephritis (LN, lupus-related kidney disease). In addition, individuals with both lupus and CKD...
